Discovery of orally active indirubin-3′-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemiaPyeonghwa Jeong, Yeongyu Moon, So‐Deok Lee et al.|European Journal of Medicinal Chemistry|2020Cited by 29
Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemiaJi Eun Shin, Hyun Woo Park|Molecular Cancer|2023Cited by 27